Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Aurobindo Pharma arm CuraTeQ Biologics incorporates new wholly owned subsidiary in Malta

Aurobindo Pharma arm incorporates new wholly owned subsidiary in Malaysia

Ruchika Sharma18 Sept 2025 2:56 PM IST

Aurobindo Pharma has announced that Helix Healthcare B.V., a wholly owned subsidiary of the Company, has incorporated a new wholly owned subsidiary in...

Natco Pharma gets USFDA EIR for Kothur Pharma division

Ruchika Sharma18 Sept 2025 12:52 PM IST

Hyderabad: Natco Pharma has announced that the U.S. Food and Drug Administration (USFDA) has issued Establishment Inspection Report (EIR) for the...

Zydus Wellness acquires UK based Comfort Click

Roche to acquire 89bio for up to USD 3.5 billion

Ruchika Sharma18 Sept 2025 11:30 AM IST

Basel: Roche has announced that it has entered into a definitive merger agreement to acquire 89bio, Inc., a publicly listed clinical-stage...

Zydus Liesciences secures USFDA okay for Duchenne Muscular Dystrophy drug

Lupin bags USFDA approval for Multiple myeloma treatment

Ruchika Sharma17 Sept 2025 6:19 PM IST

Mumbai: Global pharma major Lupin Limited has announced that the company has received approval from the United States Food and Drug Administration...

Biocon Opens First US Manufacturing Facility in New Jersey, Invests USD 30 Million in Expansion

Biocon Biologics wins USFDA nod for Bosaya and Aukelso, Denosumab Biosimilars

Ruchika Sharma17 Sept 2025 5:36 PM IST

Bengaluru: Biocon Biologics Ltd., a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced that the U.S. Food...

India ranks among top global contributors in adverse event reporting: DCGI

Ruchika Sharma17 Sept 2025 5:00 PM IST

New Delhi: The Indian Pharmacopoeia Commission (IPC), functioning as the National Coordination Centre for the Pharmacovigilance Programme of India...

India embraces global partnership in healthcare, anchored in Vasudhaiva Kutumbakam: DoP Secretary

Ruchika Sharma17 Sept 2025 4:04 PM IST

New Delhi: Shri Amit Agrawal, Secretary of the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, presented India’s strategic...

Merck receives positive EU CHMP opinion for Enflonsia for RSV in infants -stage small cell lung cancer

Merck gets USFDA Breakthrough Therapy Designation for Raludotatug deruxtecan for Platinum-Resistant Ovarian Cancer

Ruchika Sharma17 Sept 2025 1:03 PM IST

Rahway: Merck, Daiichi Sankyo have announced that Raludotatug deruxtecan (R-DXd) has received Breakthrough Therapy Designation (BTD) from the U.S....

Gufic Biosciences promotes Shekhar Tarbir Aley to President - Critical Care SBUs, Nepal & Institution

Ruchika Sharma17 Sept 2025 12:17 PM IST

Mumbai: Gufic Biosciences has announced the promotion of Shekhar Tarbir Aley from Senior Vice President - Critical Care SBUs, Nepal &...

USFDA concludes inspection at Zydus Lifesciences SEZ II, Ahmedabad plant

Lupin gets 6 USFDA observations for Nagpur facility

Ruchika Sharma17 Sept 2025 11:00 AM IST

Mumbai: Lupin has announced that the U.S. Food and Drugs Administration (USFDA) has closed the inspection with six observations at the company's...

MedTech sector is a key pillar of health transformation in India: JP Nadda

Ruchika Sharma16 Sept 2025 5:09 PM IST

New Delhi: MedTech sector is a key pillar of health transformation in India, Union Minister for Health and Family Welfare and Chemicals and...

Ravenbhel Gets SEC Nod to Market Bilastine, Montelukast FDC, Phase IV Trial Mandated

Department of Pharma begins preparations for Special Campaign 5.0

Ruchika Sharma16 Sept 2025 4:00 PM IST

New Delhi: The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has initiated preparations for Special Campaign for Disposal of...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok